Wambach G, Higgins J R, Kem D C, Kaufmann W
Acta Endocrinol (Copenh). 1979 Nov;92(3):560-7. doi: 10.1530/acta.0.0920560.
Progesterone increases urinary sodium excretion at least in part by competition for renal mineralocorticoid receptors. In contrast, synthetic progestagens do not increase sodium excretion or even cause a slight sodium retention. We therefore compared the ability of progesterone and 12 progesterone like compounds to displace [3H]aldosterone from binding at cytoplasmic mineralocorticoid receptors in rat kidney. All synthetic progesteronelike steroids were less active than progesterone in competing with [3H]aldosterone for the receptor binding: progesterone 100%, 11 beta-OH progesterone 50%, 17 alpha OH-progesterone 24% and 16 alpha-methyl-progesterone 3%. Derivates of 17 alpha OH-progesterone (medrogestone 5%, dydrogestone 4%, medroxy progesterone-acetate 2% and chlormadinone-acetate 0.5%) were more potent than 19-nor-testosterone derivates: ethisterone 1%, norethisterone less than 1%, norethindrone less than 1%, norethyl-nodrel less than 1%, and ethynodiol-diacetate less than 1%. The decreased affinity of synthetic progestins for mineralocorticoid receptors explains in part the lack of natriuretic activity of these compounds.
孕酮至少部分地通过竞争肾脏盐皮质激素受体来增加尿钠排泄。相比之下,合成孕激素不会增加钠排泄,甚至会导致轻微的钠潴留。因此,我们比较了孕酮和12种孕酮类似化合物在大鼠肾脏细胞质盐皮质激素受体上取代[3H]醛固酮结合的能力。所有合成孕酮类甾体在与[3H]醛固酮竞争受体结合方面的活性均低于孕酮:孕酮为100%,11β-羟基孕酮为50%,17α-羟基孕酮为24%,16α-甲基孕酮为3%。17α-羟基孕酮的衍生物(甲地孕酮为5%,二氢孕酮为4%,醋酸甲羟孕酮为2%,醋酸氯地孕酮为0.5%)比19-去甲睾酮衍生物更有效:炔孕酮为1%,炔诺酮小于1%,炔诺孕酮小于1%,异炔诺酮小于1%,炔雌醇二乙酸酯小于1%。合成孕激素对盐皮质激素受体亲和力的降低部分解释了这些化合物缺乏利钠活性的原因。